Li Tian-Cheng, Takeda Naokazu, Miyamura Tatsuo, Matsuura Yoshiharu, Wang Joseph C Y, Engvall Helena, Hammar Lena, Xing Li, Cheng R Holland
Department of Virology II, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo, Japan.
J Virol. 2005 Oct;79(20):12999-3006. doi: 10.1128/JVI.79.20.12999-13006.2005.
Hepatitis E virus (HEV) is a noncultivable virus that causes acute liver failure in humans. The virus's major capsid protein is encoded by an open reading frame 2 (ORF2) gene. When the recombinant protein consisting of amino acid (aa) residues 112 to 660 of ORF2 is expressed with a recombinant baculovirus, the protein self-assembles into virus-like particles (VLPs) (T.-C. Li, Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura, J. Virol. 71:7207-7213, 1997). VLPs can be found in the culture medium of infected Tn5 cells but not in that of Sf9 cells, and the major VLPs have lost the C-terminal 52 aa. To investigate the protein requirement for HEV VLP formation, we prepared 14 baculovirus recombinants to express the capsid proteins truncated at the N terminus, the C terminus, or both. The capsid protein consisting of aa residues 112 to 608 formed VLPs in Sf9 cells, suggesting that particle formation is dependent on the modification process of the ORF2 protein. In the present study, electron cryomicroscopy and image processing of VLPs produced in Sf9 and Tn5 cells indicated that they possess the same configurations and structures. Empty VLPs were found in both Tn5 and Sf9 cells infected with the recombinant containing an N-terminal truncation up to aa residue 125 and C-terminal to aa residue 601, demonstrating that the aa residues 126 to 601 are the essential elements required for the initiation of VLP assembly. The recombinant HEV VLPs are potential mucosal vaccine carrier vehicles for the presentation of foreign antigenic epitopes and may also serve as vectors for the delivery of genes to mucosal tissue for DNA vaccination and gene therapy. The results of the present study provide useful information for constructing recombinant HEV VLPs having novel functions.
戊型肝炎病毒(HEV)是一种不可培养的病毒,可导致人类急性肝衰竭。该病毒的主要衣壳蛋白由开放阅读框2(ORF2)基因编码。当由ORF2的氨基酸(aa)残基112至660组成的重组蛋白用重组杆状病毒表达时,该蛋白会自组装成病毒样颗粒(VLP)(T.-C. Li、Y. Yamakawa、K. Suzuki、M. Tatsumi、M. A. Razak、T. Uchida、N. Takeda和T. Miyamura,《病毒学杂志》71:7207 - 7213,1997年)。VLP可在感染的Tn5细胞的培养基中发现,但在Sf9细胞的培养基中未发现,并且主要的VLP失去了C末端的52个氨基酸。为了研究HEV VLP形成所需的蛋白质,我们制备了14种杆状病毒重组体,以表达在N末端、C末端或两者都被截断的衣壳蛋白。由aa残基112至608组成的衣壳蛋白在Sf9细胞中形成了VLP,这表明颗粒形成依赖于ORF2蛋白的修饰过程。在本研究中,对在Sf9和Tn5细胞中产生的VLP进行的电子冷冻显微镜和图像处理表明,它们具有相同的构型和结构。在感染了含有N末端截断至aa残基125且C末端至aa残基601的重组体的Tn5和Sf9细胞中均发现了空的VLP,这表明aa残基126至601是VLP组装起始所需的必需元件。重组HEV VLP是用于呈递外源抗原表位的潜在黏膜疫苗载体,也可作为将基因递送至黏膜组织用于DNA疫苗接种和基因治疗的载体。本研究结果为构建具有新功能的重组HEV VLP提供了有用信息。